Beacon Dermatology Inc /ID# 213003

Calgary, Alberta T3E 0B2

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis

Studies at this site

• A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis — Completed